HCW Biologics Inc. (HCWB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.04M |
| Enterprise Value | 6.89M |
| P/E Ratio | -0.14 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.37 |
| Price/Book Ratio | 0.42 |
| Enterprise/Revenue | 1.18 |
| Enterprise/EBITDA | -12.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -0.25 |
| Operating Margin | -0.98 |
| Return On Assets | -0.06 |
| Return On Equity | -1.02 |
| Revenue | 54,232 |
| Revenue/Share | 3.14 |
| Gross Profit | 10,846 |
| EBITDA | -5.67M |
| Net Income | -7.96M |
| Diluted EPS | -10.63 |
| Total Cash | 1.23M |
| Total Cash/Share | 0.59 |
| Total Debt | 6.58M |
| Total Debt/Equity | 1.14 |
| Current Ratio | 0.09 |
| Book Value Per Share | 2.75 |
| 52-Week Change | -75.16 |
| 52-Week High | 7.35 |
| 52-Week Low | 0.25 |
| Moving Average 50 Days | 1.01 |
| Moving Average 200 Days | 1.82 |
| Average Volume | 12.92M |
| Shares Outstanding | 2.09M |
| % Held by Institutions | 21.44 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | April 11, 2025 |